<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_UC_Davis_Notebook_Week_5"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:UC_Davis/Notebook/Week_5">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:UC_Davis/Notebook/Week_5&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:UC_Davis/Notebook/Week_5&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:UC_Davis/Notebook/Week_5&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:UC_Davis/Notebook/Week_5" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform">Â </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:UC Davis/Notebook/Week 5</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><P><UL class="nav"><LI class="dropdown leftbookend"><A href="/Team:UC_Davis" style="font-size:13px;">Home</A></LI><LI class="dropdown leftbookend rightbookend"><A href="https://2013.igem.org/Team:UC_Davis/Team_Overview" style="font-size:13px;">Team</A></LI><LI><A href="https://2013.igem.org/Team:UC_Davis/Team_Overview">Overview</A></LI><LI><A href="https://2013.igem.org/Team:UC_Davis/Bios">Bios</A></LI><LI><A href="/Team:UC_Davis/Contact">Contact Us</A></LI><LI><A href="https://igem.org/Team.cgi?id=1212">Official Team Profile</A></LI></UL><LI class="dropdown leftbookend rightbookend"><A href="https://2013.igem.org/Team:UC_Davis/Project_Overview" style="font-size:13px;">Project</A></LI><LI><A href="https://2013.igem.org/Team:UC_Davis/Project_Overview">Overview</A></LI><LI><A href="/Team:UC_Davis/Modeling">Modeling</A></LI><LI><A href="/Team:UC_Davis/Assembly">Assembly</A></LI><LI><A href="/Team:UC_Davis/Parts">Parts</A></LI><LI><A href="/Team:UC_Davis/Safety">Safety</A></LI><LI class="dropdown leftbookend rightbookend"><A href="/Team:UC_Davis/Data" style="font-size:13px;">Data</A></LI><LI><A href="/Team:UC_Davis/Data">Testing Constructs</A></LI><LI><A href="/Team:UC_Davis/AndersonPromoters">Anderson Promoters</A></LI><LI><A href="/Team:UC_Davis/AndersonPromoters2">Anderson II</A></LI><LI class="dropdown leftbookend rightbookend"><A href="/Team:UC_Davis/Notebook_Overview" style="font-size:13px;">Notebook</A></LI><LI><A href="/Team:UC_Davis/Notebook">Notebook</A></LI><LI><A href="/Team:UC_Davis/Protocols">Protocols</A></LI><LI><A href="https://2013.igem.org/Team:UC_Davis/Gallery">Gallery</A></LI><LI><A href="https://2013.igem.org/Team:UC_Davis/Attributions">Attributions</A></LI><LI class="dropdown rightbookend"><A href="/Team:UC_Davis/HumanPracticesOverview" style="font-size:13px;">Human Practices</A></LI><LI><A href="/Team:UC_Davis/HumanPracticesOverview">Overview</A></LI><LI><A href="/Team:UC_Davis/Outreach">Outreach</A></LI><LI><A href="/Team:UC_Davis/Database">The Depot</A></LI></P><TABLE class="linktable"><TBODY><TR><TD><SPAN class="weeklink" id="zero">June 19-21</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook">0</A></TD></TR><TR><TD><SPAN class="weeklink" id="one">June 24-28</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_1">1</A></TD></TR><TR><TD><SPAN class="weeklink" id="two">July 1-5</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_2">2</A></TD></TR><TR><TD><SPAN class="weeklink" id="three">July 8-12</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_3">3</A></TD></TR><TR><TD><SPAN class="weeklink" id="four">July 15-19</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_4">4</A></TD></TR><TR><TD><SPAN class="weeklink" id="five">July 22-26</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_5">5</A></TD></TR><TR><TD><SPAN class="weeklink" id="six">July 29-August 2</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_6">6</A></TD></TR><TR><TD><SPAN class="weeklink" id="seven">August 5-9</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_7">7</A></TD></TR><TR><TD><SPAN class="weeklink" id="eight">August 12-16</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_8">8</A></TD></TR><TR><TD><SPAN class="weeklink" id="nine">August 19-24</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_9">9</A></TD></TR><TR><TD><SPAN class="weeklink" id="ten">August 26-31</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_10">10</A></TD></TR><TR><TD><SPAN class="weeklink" id="eleven">September 1-7</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_11">11</A></TD></TR><TR><TD><SPAN class="weeklink" id="twelve">September 8-14</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_12">12</A></TD></TR><TR><TD><SPAN class="weeklink" id="thirteen">September 15-21</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_13">13</A></TD></TR><TR><TD><SPAN class="weeklink" id="fourteen">September 22-28</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_14">14</A></TD></TR><TR><TD><SPAN class="weeklink" id="fifteen">September 30-October 28</SPAN><A href="https://2013.igem.org/Team:UC_Davis/Notebook/Week_15">15+</A></TD></TR></TBODY></TABLE><DIV class="floatnotebook"><H1 class="title">Week 5</H1><P>7/22/13
                     We ran two different restriction digests for <A href="http://parts.igem.org/Part:BBa_K750000">BBa_K750000</A> and <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> as part of our protocol for site-directed mutagenesis by PCR. According to the restriction digest, there were no bands present in the lanes containing the <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> digest. There were bands of appropriate size for <A href="http://parts.igem.org/Part:BBa_K750000">BBa_K750000</A>. We decided to transform the DNA within the restriction digest anyways. We also measured the DNA concentrations for the two TAL repressors. The transformations of <A href="http://parts.igem.org/Part:BBa_K598010">BBa_K598010</A> and <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> were successful and were inoculated in LB for further culturing. We ordered primers for GFP, TAL repressors, and our two different plasmid backbones, which will be used in Golden Gate Assembly. We also cultured a strain of E. coli, MG1665Z1 that endogenously expresses LacI, TetR, and AraC. We will use this for our construct.
                     7/23/13
                     Our overnight cultures for <A href="http://parts.igem.org/Part:BBa_K598010">BBa_K598010</A>, <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> and MG1665Z1 all looked good.  A portion of the cultures were saved as glycerol stocks, and <A href="http://parts.igem.org/Part:BBa_K598010">BBa_K598010</A> and <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> were miniprepped. The transformation of the mutant <A href="http://parts.igem.org/Part:BBa_K750000">BBa_K750000</A> was successful and was inoculated in LB for further culturing. However, the transformation of the mutated <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> was not successful, which was reasonable considering the lack of any bands on the gel we ran yesterday. In light of this failure, we realized that <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> actually had an insert part that we neglected to take into account for in our site-directed mutagenesis reaction which we corrected and repeated today for both the previous miniprep and the one that we performed today. We also began making MG1665Z1 competent for future use in our constructs.
                     7/24/13
                     We sent in the mutant DNA miniprep of <A href="http://parts.igem.org/Part:BBa_K750000">BBa_K750000</A> for sequencing to see if our site-directed mutagenesis actually worked. The transformations of the mutant <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> were successful, so we started one LB culture to grow overnight. We made new competent cells with MG1665Z1, so that we could use them for future constructs.  We are testing our new competent cells by transforming them with mutant <A href="http://parts.igem.org/Part:BBa_K750000">BBa_K750000</A> and <A href="http://parts.igem.org/Part:BBa_K598010">BBa_K598010</A>. In addition, we realized that we were running out of LB and decided to make an additional batch for the lab along with additional LB plates containing ampicillin.7/25/13
                     The newly made competent cells were successful in taking up DNA for <A href="http://parts.igem.org/Part:BBa_K750000">BBa_K750000</A> and <A href="http://parts.igem.org/Part:BBa_K598010">BBa_K598010</A>. Both were cultured in LB for us to use as a test for induction and GFP measurements tomorrow. The site-directed mutagenesis for <A href="http://parts.igem.org/Part:BBa_K750000">BBa_K750000</A> was also successful, so there is no longer a BsaI site in the sequencing results. We did a miniprep of the mutant <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> and plan to send the plasmid out for sequencing when primers have been ordered. However, we may not use <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> until after we have created our entire construct on one plasmid and then we shall decide to vary copy number. After looking at the primers that were used for site-directed mutagenesis, we realized that they were targeting a false BsaI site. Therefore, any of the work done with <A href="http://parts.igem.org/Part:pSB3K3">pSB3K3</A> would have to be done with newly ordered primers that will hopefully be received by next week.

                     7/26/13
                     We made stock solutions of arabinose and theophylline for future testing. The cultures containing <A href="http://parts.igem.org/Part:BBa_K750000">BBa_K750000</A> and <A href="http://parts.igem.org/Part:BBa_K598010">BBa_K598010</A> were too turbid for Tecan testing, so we grew out the cultures to ideal optical density. After growing our cultures to an OD600 of 0.5, we tried out a TECAN test trial with <A href="http://parts.igem.org/Part:BBa_K750000">BBa_K750000</A> and <A href="http://parts.igem.org/Part:BBa_K598010">BBa_K598010</A>. We aliquoted varying concentrations of theophylline and arabinose and decided to run a trial over night to test the behavior of these two constructs. In our spare time, we learned more about HTML5 for updating our Wiki.
</P></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:UC_Davis/Notebook/Week_5">http://2013.igem.org/Team:UC_Davis/Notebook/Week_5</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:UC_Davis/Notebook/Week_5" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:UC_Davis/Notebook/Week_5" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:UC_Davis/Notebook/Week_5&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:UC_Davis/Notebook/Week_5&amp;oldid=224371" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>